Astellas Pharma Inc.: Announcement of Regulatory Submission for Mirabegron (YM178), a

  • 31. August 2011
No Comments

TOKYO, Aug. 28, 2011 /PRNewswire/ –Astellas Pharma Inc. today announced the submission of a NewDrug Application and Market Authorisation Application formirabegron (generic name / code name: YM178) to the U.S. Food andDrug Administration and…

Weiterlesen…
Via (link nur für registrierte Benutzer sichtbar, login oder registriere dich)

Incoming search terms:

  • mirabegron
  • мирабегрон

  • lek mirabegron
  • what is the codename for surfaxin?
  • mirabegron
  • hanfsamen pharma
  • oy astellas
  • apf530, actualmente en pre-registro
  • astellas pharma inc
  • előterjesztés submission
  • мірабегрон
  • astellas oy

 

More from our blog

See all posts
No Comments